摘要
由于在当代药物化学杂志中一部分作者的疏忽,2013, 20(1), 144-157一篇由Dulinska-Litewka J, McCubrey JA 和 Laidler P所写的名为“在前列腺癌症中由于雄性激素响应能力的缺失导致的Akt蛋白分子信号的增强”中,出现了一处错误。由UJCM研究委员会分配的一项课题编号很不幸的没有被书写完全。谨慎考虑到这个项目在每次国际会议摘要,发表论文和书籍中的章节的出现,由NCN给予的编号必须是正确的。在这篇文章中被错误给予的编号是“K/PBW/ 000561”,然而它正确的编号应该是“K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38)”。我文章的正确的致谢部分如下:
Current Medicinal Chemistry
Title:ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157.
Volume: 21 Issue: 32
Author(s): Joanna Dulinska-Litewka
Affiliation:
摘要: Due to an oversight on the part of the authors in Current Medicinal Chemistry, 2013, 20(1), 144-157 of article entitled “Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer” by Dulinska-Litewka J, McCubrey JA and Laidler P, one slip-up was encountered. The project number assigned by the Commission to research UJCM was unfortunately not written completely. To close accounting on this project on each of the presented abstracts from International Meeting - Conferences, publications and chapters in books, the number assigned by the NCN must be given.
The number which was published was K/PBW/ 000561 but it should have been K/PBW/ 000561 - N N401 125638 (1256/B/P01/2010/38). The correct acknowledgement section of my manuscript should be as follows:
Export Options
About this article
Cite this article as:
Dulinska-Litewka Joanna, ADDENDUM: Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer. Dulinska-Litewka J, McCubrey JA, Laidler P. Curr. Med. Chem., 2013, 20(1), 144-157., Current Medicinal Chemistry 2014; 21 (32) . https://dx.doi.org/10.2174/092986732132140930102757
DOI https://dx.doi.org/10.2174/092986732132140930102757 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Radiosensitization in Prostate Cancer
Current Pharmaceutical Design Molecular Processes in Cancers and Cancer Chemotherapy
Current Chemical Biology Electroporation in DNA Vaccination Protocols Against Cancer
Current Drug Metabolism Potential Non-coding RNAs from Microorganisms and their Therapeutic Use in the Treatment of Different Human Cancers
Current Gene Therapy HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Evaluation of Novel Erucin Analogues as Potential Antitumor Compounds
Letters in Organic Chemistry Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma
Medicinal Chemistry Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
Current Cancer Drug Targets Applied Computational Techniques on Schizophrenia Using Genetic Mutations
Current Topics in Medicinal Chemistry Death Receptors as Targets of Cancer Therapeutics
Current Cancer Drug Targets Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Role of Genomics-Based Strategies in Overcoming Chemotherapeutic Resistance
Current Pharmaceutical Biotechnology 2D-Gel Electrophoresis Analysis of Proteomic Changes in Three Human Cell Lines; HEK 293, HepG2 and 1321N1 Cells in Response to Cadmium
Current Proteomics Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mirware: A MiRNA-mRNA Warehouse for Inference on Their Coordination
MicroRNA Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Current Gene Therapy Modulating Mitochondria-Mediated Apoptotic Cell Death through Targeting of Bcl-2 Family Proteins
Recent Patents on DNA & Gene Sequences SCYL1-BP1 Affects Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells via Cyclin F and RRM2
Anti-Cancer Agents in Medicinal Chemistry